Loading publications…
The last 5 uploaded publications
P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials
Marco Valgimigli, Felice Gragnano, Mattia Branca, Anna Franzone, Usman Baber, Yangsoo Jang, Takeshi Kimura, Joo‐Yong Hahn, Qiang Zhao, Stephan Windecker, C. Michael Gibson, Byeong‐Keuk Kim, Hirotoshi Watanabe, Young Bin Song, Yunpeng Zhu, Pascal Vranckx, Shamir R. Mehta, Sung‐Jin Hong, Kenji Andò, Hyeon‐Cheol Gwon, Patrick W. Serruys, George Dangas, Eugène McFadden, Dominick J. Angiolillo, Dik Heg, Peter Jüni, Roxana Mehran (2021). P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials. BMJ, pp. n1332-n1332, DOI: 10.1136/bmj.n1332.
Article146 days agoP2Y12 Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary Interventions
Felice Gragnano, Roxana Mehran, Mattia Branca, Anna Franzone, Usman Baber, Yangsoo Jang, Takeshi Kimura, Joo‐Yong Hahn, Qiang Zhao, Stephan Windecker, C. Michael Gibson, Byeong‐Keuk Kim, Hirotoshi Watanabe, Young Bin Song, Yunpeng Zhu, Pascal Vranckx, Shamir R. Mehta, Sung‐Jin Hong, Giuseppe Andò, Hyeon‐Cheol Gwon, Paolo Calabrò, Patrick W. Serruys, George Dangas, Eugène McFadden, Dominick J. Angiolillo, Dik Heg, Marco Valgimigli (2023). P2Y12 Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary Interventions. Journal of the American College of Cardiology, 81(6), pp. 537-552, DOI: 10.1016/j.jacc.2022.11.041.
Article146 days agoTicagrelor or Clopidogrel Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
Marco Valgimigli, Felice Gragnano, Mattia Branca, Anna Franzone, Bruno R. da Costa, Usman Baber, Takeshi Kimura, Yangsoo Jang, Joo‐Yong Hahn, Qiang Zhao, Stephan Windecker, C. Michael Gibson, Hirotoshi Watanabe, Byeong‐Keuk Kim, Young Bin Song, Yunpeng Zhu, Pascal Vranckx, Shamir R. Mehta, Giuseppe Andò, Sung‐Jin Hong, Hyeon‐Cheol Gwon, Patrick W. Serruys, George Dangas, Eugène McFadden, Dominick J. Angiolillo, Dik Heg, Paolo Calabrò, Peter Jüni, Roxana Mehran (2024). Ticagrelor or Clopidogrel Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention. JAMA Cardiology, 9(5), pp. 437-437, DOI: 10.1001/jamacardio.2024.0133.
Article146 days agoTicagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting
Anna Franzone, Eugène McFadden, Sergio Leonardi, Raffaele Piccolo, Pascal Vranckx, Patrick W. Serruys, Edouard Benit, Christoph Liebetrau, Luc Janssens, Maurizio Ferrario, Aleksander Żurakowski, Roberto Diletti, Marcello Dominici, Kurt Huber, Ton Slagboom, Paweł Buszman, Leonardo Bolognese, Carlo Tumscitz, Krzysztof Bryniarski, Adel Aminian, Mathias Vrolix, Ivo Petrov, Scot Garg, Christoph Naber, Janusz Prokopczuk, Christian W. Hamm, Philippe Gabríel Steg, Dik Heg, Peter Jüni, Stephan Windecker, Marco Valgimigli (2019). Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting. Journal of the American College of Cardiology, 74(18), pp. 2223-2234, DOI: 10.1016/j.jacc.2019.08.1038.
Article146 days agoImpact of Diabetic Status on Outcomes After Revascularization With Drug-Eluting Stents in Relation to Coronary Artery Disease Complexity
Konstantinos C. Koskinas, George C.M. Siontis, Raffaele Piccolo, Anna Franzone, Alan G. Haynes, Julie Rat-Wirtzler, Sigmund Silber, Patrick W. Serruys, Thomas Pilgrim, Lorenz Räber, Dik Heg, Peter Jüni, Stephan Windecker (2016). Impact of Diabetic Status on Outcomes After Revascularization With Drug-Eluting Stents in Relation to Coronary Artery Disease Complexity. Circulation Cardiovascular Interventions, 9(2), DOI: 10.1161/circinterventions.115.003255.
Article146 days ago